Characterization of the Blood–Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of the Blood–Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 5, Pages 399
Publisher
MDPI AG
Online
2020-04-29
DOI
10.3390/pharmaceutics12050399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
- (2018) Mara Vinci et al. NATURE MEDICINE
- Targeted unlabeled multiple reaction monitoring analysis of cell markers for the study of sample heterogeneity in isolated rat brain cortical microvessels
- (2017) David Gomez-Zepeda et al. JOURNAL OF NEUROCHEMISTRY
- New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis
- (2017) Alexandre Plessier et al. Oncotarget
- Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
- (2017) Tammy Hennika et al. PLoS One
- Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood–Brain Barrier
- (2016) Catarina Chaves et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model
- (2016) R. K. Mittapalli et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells
- (2016) Katherine L. Misuraca et al. NEOPLASIA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib
- (2015) Mark C. de Gooijer et al. INVESTIGATIONAL NEW DRUGS
- Tumor location, but not H3.3K27M, significantly influences the blood–brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma
- (2015) Ergys Subashi et al. JOURNAL OF NEURO-ONCOLOGY
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
- (2015) Catherine S Grasso et al. NATURE MEDICINE
- Efflux transporters in blood-brain interfaces of the developing brain
- (2015) Nathalie Strazielle et al. Frontiers in Neuroscience
- DIPG in Children – What Can We Learn from the Past?
- (2015) Magimairajan Issai Vanan et al. Frontiers in Oncology
- Optimized Approaches for Quantification of Drug Transporters in Tissues and Cells by MRM Proteomics
- (2014) Bhagwat Prasad et al. AAPS Journal
- aLFQ: an R-package for estimating absolute protein quantities from label-free LC-MS/MS proteomics data
- (2014) George Rosenberger et al. BIOINFORMATICS
- Irinotecan and temozolomide brain distribution: a focus on ABCB1
- (2014) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Convection enhanced delivery of carmustine to the murine brainstem: A feasibility study
- (2014) A. Charlotte P. Sewing et al. JOURNAL OF NEUROSCIENCE METHODS
- Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
- (2014) Kathryn R Taylor et al. NATURE GENETICS
- Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues
- (2013) F. Lin et al. CLINICAL CANCER RESEARCH
- Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
- (2013) Yutaro Hoshi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Treatment of Children with Diffuse Intrinsic Pontine Gliomas with Chemoradiotherapy Followed by a Combination of Temozolomide, Irinotecan, and Bevacizumab
- (2013) Wafik Zaky et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma
- (2013) Susanna J. E. Veringa et al. PLoS One
- Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
- (2012) Sagar Agarwal et al. CURRENT PHARMACEUTICAL DESIGN
- An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing
- (2012) Yasuyuki Aoki et al. JOURNAL OF NEURO-ONCOLOGY
- Diffuse intrinsic pontine glioma—current status and future strategies
- (2011) Soumen Khatua et al. CHILDS NERVOUS SYSTEM
- Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience
- (2011) Johannes E. Wolff et al. JOURNAL OF NEURO-ONCOLOGY
- Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
- (2011) Ramzi Shawahna et al. MOLECULAR PHARMACEUTICS
- Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone
- (2010) H. Kodaira et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid
- (2009) J. Shen et al. CANCER RESEARCH
- Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors
- (2009) Wayne L. Furman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N- -6-[5-( methyl)-2-furyl]-4-quinazolinamine; GW572016)
- (2008) J. W. Polli et al. DRUG METABOLISM AND DISPOSITION
- Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats
- (2008) Tripta Bansal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- In Situ Mouse Carotid Perfusion Model: Glucose and Cholesterol Transport in the Eye and Brain
- (2008) Julie Cattelotte et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A Children's Oncology Group phase I study
- (2008) Kristin A. Bradley et al. NEURO-ONCOLOGY
- Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria
- (2008) Junichi Kamiie et al. PHARMACEUTICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started